Gregory W. Schafer, Director at Nile Therapeutics, Inc. (NILT.OB), bought 100 shares at $4.60 ($460) on 2008-04-15, disclosed to the SEC on 2008-04-16.
Open-market purchase of $460 NILT.OB by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| ADRO | SELL | 2017-11-08 | $159K | — | Filing → |
| ADRO | SELL | 2017-10-04 | $215K | — | Filing → |
| ADRO | SELL | 2017-09-14 | $53K | — | Filing → |